Valuation Supriya Lifescience Limited

Stocks

End-of-day quote NSE India S.E. 2026-10-28			5-day change	1st Jan Change
862.25 ^INR	+1.33%		+2.33%	+14.74%

09-25	Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026	CI
08-14	Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	39,702	15,352	26,797	59,086	45,223	69,396	-	-
Change	-	-61.33%	74.55%	120.5%	-23.46%	53.45%	-	-
Enterprise Value (EV)	39,702	15,352	26,797	59,086	45,223	69,396	69,396	69,396
Change	-	-61.33%	74.55%	120.5%	-23.46%	53.45%	0%	0%
P/E	26.2x	17.1x	22.5x	31.4x	21.6x	29.2x	22.2x	17.4x
PBR	-	-	-	-	3.78x	4.86x	4.01x	3.27x
PEG	-	-0.4x	0.7x	0.5x	1.9x	2.2x	0.7x	0.6x
Capitalization / Revenue	-	3.33x	4.7x	8.48x	5.46x	6.99x	5.59x	4.47x
EV / Revenue	-	0x	0x	0x	0x	6.99x	5.59x	4.47x
EV / EBITDA	-	0x	0x	0x	0x	20.2x	15.7x	12.4x
EV / EBIT	-	-	0x	0x	0x	22.9x	17.6x	13.8x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	18.86	11.16	14.8	23.35	25.98	29.5	38.8	49.6
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	4,609	5,704	6,965	8,279	9,935	12,418	15,523
EBITDA ¹	-	1,289	1,730	2,608	2,940	3,427	4,408	5,588
EBIT ¹	-	-	1,572	2,404	2,656	3,032	3,933	5,033
Net income ¹	1,518	898.6	1,191	1,880	2,091	2,372	3,122	3,993
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	493.30	190.75	332.95	734.15	561.90	862.25	862.25	862.25
Nbr of stocks (in thousands)	80,483	80,483	80,483	80,483	80,483	80,483	-	-
Announcement Date	5/20/22	5/26/23	5/28/24	5/27/25	5/27/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUPRIYA LIFESCIENCE LIMITED	28.84x	-	-	-	721M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.51x	7.09x	18.77x	2.12%	402.83B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%